Breakthrough Technology: Success of Barcodes on Vaccine Inventory Management

Rehana Wolfe, Pfizer

Director, Developing World, Vaccines at Pfizer

April 4-6, 2017

© GS1 2017

Introduction

2

Rehana Wolfe, M.A.Vaccine Lead, Global Developing WorldResponsible for the introduction and support of PCV 13 vaccination programs in Gavi Eligible Countries in the Pfizer-Gavi Partnership

© GS1 2017

Agenda

3

• Background

• The Challenge

• A Solution

• Pfizer’s 2D Barcode Pilot Program

• Partnership

• Conclusion

© GS1 2017 4

Background

Children in developing countries are ten times more likely to die before the age of five than children in developed countries.

© GS1 2017 5

Background

Simple interventions can save many young lives each year.

Clean Water

Vaccination

Nutrition

© GS1 2017 6

The Challenge

Are vaccines getting to the children in need?

© GS1 2017 7

A Solution - Barcodes

A focus on vaccine presentation and packaging.

© GS1 2017 8

Why a Barcode?

All system data is hosted centrally on a server – no need for local system copies at each site location

Scanning the 2D barcode will eliminate human data entry errors

Scanning will speed up data entry

Real-time inventory reporting allows for quicker decision-making at intermediate and central levels

Accuracy Efficiency

Visibility Data Security

© GS1 2017 9

Barcode Landscape in the Developing World

Barcode Proof of

Principle in Tanzania

Ethiopia Pilot for E2E

Supply Chain Visibility

Implementation of GS1

Standards in Pakistan

© GS1 2017 10

Pfizer’s 2D Barcode Pilot Program

• Demonstrate compelling evidence and advance the dialogue

• Enrich open-source supply chain solutions

• Accelerate impact on global health

Program Objectives

PILOT SITES

1. Cenabi

2. Managua

3. Masaya

4. León

5. Francisco Buitrago

6. Masatepe

7. Mantica Berio

National StoreCentral level

Districts/SILAISSecondary Level

MunicipalitiesTertiary level

Health Centers*Last Mile

© GS1 2017

Implementation Methodology

11

PILOT

EVALUATION*

PILOT

MONITORING

DEPLOY &

PILOT

BUILD & TEST

DESIGN

SCOPING &

PLANNING

July2015

Aug 2015

Sept 2015

Oct & Nov2015

Dec2015

Jan-Apr2016

*Pilot Extension through April 2016

Pilot period extended

Feedback gathering

Monitored system usage directly after go-live

Continued to troubleshoot system issues on an ongoing basis

Rolled out 2D barcoding solution to 7 sites

Conducted user training

Completed system development

Delivered finalized technical design specifications

Reviewed current MoH processes

Conducted gap assessment

© GS1 2017

Results

12

• All system data hosted centrally

• Removes need for local system copies at each site location, reducing data management costs and possible security breaches

Accuracy Efficiency

Data Security

Total number of adjustments made across all

levels:

One in 223 Transactions

Visibility and Operational

Ability to see stocks at all levels:

All levels of system used

100%

Manual entry: 1 minuteScanned entry: 18 seconds

68% less time needed for one transaction vs. manual system

© GS1 2017 13

Call to Action

It’s time to partner together – both governments and pharmaceutical companies – to operationalize and improve technology for the most impact.

What We Need:

• Government participation

• Pharma EPI programs alignment

• Alliance partners engagement

• Get the message out!

• Make this a priority

© GS1 2017 14

Conclusion

Barcode technology can increase access to potentially life saving vaccines.

© GS1 2017 15

Thank You!

All of the opinions expressed in this presentation are mine and do not necessarily reflect the opinion of Pfizer

© GS1 2017 16

Q&A Session

© GS1 2017

Contact Information

17

Rehana B. Wolfe

Director, Developing World, Vaccines at Pfizer

+1 (484) 865-5517

www.gs1.org

Rehana.Wolfe@Pfizer.com

Pfizer

500 Arcola Road

Collegeville, PA 19468

+1 (484) 524-3717

T

M

E